With the creation of the Oncobreast Chair at the Toulouse Cancer Center, the Toulouse Cancer Santé Foundation, TotalEnergies, Inserm and Oncopole are together investing €2 million in breast cancer research.
Press release Toulouse Cancer Santé Foundation, Inserm and Toulouse University Cancer Institute Oncopole
In September 2022, Inserm, the Toulouse Cancer Santé Foundation and Oncopole jointly launched a call for candidates for the creation of a research chair aimed at advancing research in the field of triple-negative breast cancer (TNBC). They selected Doctor Lorenzo Scipioni, 36, a postdoctoral researcher in the Department of Biomedical Engineering at the University of California at Irvine in the USA, who has recently moved to Toulouse to join the Centre de Recherches en Cancérologie de Toulouse (CRCT – Unité mixte de recherche Inserm, CNRS et Université Toulouse III Paul Sabatier).
